Advocacy groups, providers and virtual care companies said clinicians and pharmacies need time to comment on the rule and prepare for implementation. During the COVID-19 public health emergency, ...

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration system for the remote prescribing of controlled substances. An ...

R.I., are urging the Drug Enforcement Administration to extend federal telemedicine flexibilities for prescribing controlled substances before they expire Dec. 31. In a Dec. 2 letter to DEA ...

In an April 2 letter, a group of over 200 stakeholders urged the Drug Enforcement Administration (DEA) to release a revised proposed rule that would “permit and regulate the prescribing of controlled ...

"DEA's goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market," DEA Administrator Anne ...

With an ongoing shortage of mental health providers, particularly in rural areas, requiring patients to see doctors in-person to get prescriptions for controlled drugs severely restricts access to ...

The U.S. Drug Enforcement Agency has released its notice of proposed rulemaking for a framework to permit medically necessary controlled substances without an in-person visit without violating the ...

EXTON, Pa., Sept. 24, 2025 /PRNewswire/ -- ProRx Pharma, the leading health and wellness 503B outsourcing facility, announced today it has been awarded a DEA Controlled Substances Registration ...

The Drug Enforcement Agency has published a new final rule adjusting the fee schedule for its Diversion Control Program, which includes a more than 30 percent increase in the registration fee assessed ...